• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

BRAF V600E mutations linked with increased mortality in thyroid cancer

bys25qthea
April 11, 2013
in Chronic Disease, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. BRAF V600E mutations in patients with papillary thyroid cancer is associated with an increase in mortality.

2. Despite an association, BRAF V600E does not appear to add prognostic information after adjusting for clinical and histopathological features of the tumor.

Study Rundown: While this retrospective study observed a significant association between the BRAF V600E mutation and papillary thyroid cancer (PTC) associated mortality, statistical significance was not maintained after adjusting for clinical and histopathologic features of an aggressive tumor. The stipulated interaction between the mutation and clinicopathological factors suggests that the mutation may play a role in driving the molecular pathogenesis which leads to aggressive tumor behavior. Given that BRAF V600E testing does not seem to add more prognostic information for patients, it does not currently appear provide any utility in everyday clinical practice in the management of PTC.

Click to read the study in JAMA

Click to read an accompanying editorial in JAMA

RELATED REPORTS

Vegetarianism may be associated with a small increased risk of hypothyroidism

#VisualAbstract: Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer

Fine needle biopsy remains a reliable test for thyroid cancer diagnosis

In-Depth [retrospective, multicenter study]: This study collected patient data from 1,849 individuals with PTC treated and followed in 13 medical centers situated in 7 countries from 1978 to 2011. The overall prevalence of BRAF V600E mutation was 45.7% with an overall mortality of 3% (56/1849), 80.4% (45/56) of which were positive for BRAF V600E. Deaths per 1000 person-years was 12.87 vs. 2.52 in BRAF V600E vs. mutation negative patients with an HR of 2.66 (95% CI, 1.30-5.43). When aggressive features of the tumor (e.g. distant metastasis) were included for analysis, the association was no longer significant (HR 1.21; 95% CI, 0.53-2.76). It is notable that some of the clinicopathological factors (e.g. age, lymph node status) showed an additive interaction with the BRAF V600E mutation, significantly increasing mortality risk.

By Elizabeth Park and Rif Rahman

More from this author: Trigger exposure in migraine patients results in migraine with aura only in a small subset of patients, Choosing a prenatal diagnostic test: Microarray analysis shown equal to karyotyping, STEMO unit delivery of tpa reduces call to needle time in acute stroke patients, High-dose multivitamin supplements do not decrease disease progression or death in HIV patients receiving HAART ,Pediatric patients not receiving quality palliative care despite agreement between parents and caregivers on valued elements of care ,Combined BRAF and MEK inhibition in metastatic melanoma significantly improves progression free survival

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism.

Tags: brafthyroidthyroid cancerV600E
Previous Post

Pediatric post-operative intussusception more common in open surgery

Next Post

Everolimus only protects against early cardiac allograft vasculopathy

RelatedReports

Thyroidectomy more effective than medication for Hashimoto disease with persisting symptoms
Chronic Disease

Vegetarianism may be associated with a small increased risk of hypothyroidism

May 16, 2025
#VisualAbstract: Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis
StudyGraphics

#VisualAbstract: Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer

November 24, 2023
Patient Basics: Thyroid Cancer
Chronic Disease

Fine needle biopsy remains a reliable test for thyroid cancer diagnosis

October 19, 2022
Oncology

More permissive parameters for active surveillance eligibility is potentially possible in slow-growing thyroid cancers

September 26, 2022
Next Post
Everolimus only protects against early cardiac allograft vasculopathy

Everolimus only protects against early cardiac allograft vasculopathy

Chronic exertional compartment syndrome prevalent in the military population

Chronic exertional compartment syndrome prevalent in the military population

Home visits in Ghana improve neonatal mortality

Home visits in Ghana improve neonatal mortality

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Time-restricted eating does not confer changes in sleep, mood, or quality of life
  • Commonly cited medication triggers may not increase risk of microscopic colitis among older adults
  • Ablation may reduce stroke risk, death, heart failure hospitalization in patients with atrial fibrillation
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.